US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Seaport Therapeutics

18.04

+0.13000.73%

Volume:102.04K

Turnover:1.86M

Market Cap:965.69M

PE:-7.17

High:18.79

Open:17.99

Low:17.89

Close:17.91

52wk High:28.38

52wk Low:14.85

Shares:53.53M

Float Shares:14.16M

Volume Ratio:0.50

T/O Rate:0.72%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5160

EPS(LYR):-10.0430

ROE:-28.08%

ROA:-18.90%

PB:2.29

PE(LYR):-1.80

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

PureTech-Founded Seaport Therapeutics Unveils Strong Phase 1 Data for GlyphAgo

Seaport Therapeutics Says Drug Potentially Reduces Liver Impact of Depression Treatment

MT Newswires Live

Seaport Therapeutics presents additional PK data from Phase 1 GlyphAgo trial

Seaport Therapeutics Presents Phase 1 GlyphAgo Data Showing 6.8-Fold Increase in Agomelatine Bioavailability

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/SPTX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPTX\",,,,,undefined,":{"symbol":"SPTX","market":"US","secType":"STK","nameCN":"Seaport Therapeutics","latestPrice":18.04,"timestamp":1791574464658,"preClose":17.91,"halted":0,"volume":102042,"delay":0,"changeRate":0.007258514796203183,"floatShares":14160000,"shares":53530550,"eps":-2.516,"marketStatus":"Trading","change":0.13,"latestTime":"10-09 15:34:28 EDT","open":17.99,"high":18.79,"low":17.89,"amount":1859055.850512,"amplitude":0.050251,"askPrice":18.18,"askSize":108,"bidPrice":18.02,"bidSize":17,"shortable":3,"etf":0,"ttmEps":-2.516,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"listingDate":1777608000000,"exchange":"NASDAQ","adjPreClose":17.91,"postHourTrading":{"tag":"盘后","latestPrice":18.18,"preClose":17.91,"latestTime":"19:30 EDT","volume":2149,"amount":38601.46,"timestamp":1791502204064,"change":0.27,"changeRate":0.015075,"amplitude":0.015075},"volumeRatio":0.495168},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPTX\",,,,,undefined,":{"symbol":"SPTX","floatShares":14160000,"roa":"-18.90%","roe":"-28.08%","lyrEps":-10.043037,"volumeRatio":0.495168,"shares":53530550,"dividePrice":0,"high":18.79,"amplitude":0.050251,"preClose":17.91,"low":17.89,"week52Low":14.85,"pbRate":"2.29","week52High":28.3833,"institutionHeld":0,"latestPrice":18.04,"committee":-0.728,"eps":-2.516,"divideRate":0,"volume":102042,"delay":0,"ttmEps":-2.516,"open":17.99,"prevYearClose":18,"prevWeekClose":18.42,"prevMonthClose":20.17,"prevQuarterClose":20.17,"fiveDayClose":18.42,"twentyDayClose":23.34,"sixtyDayClose":19.52},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-03","symbol":"SPTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.71,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785729600000,"reportTimeType":"pre","actualEps":-1.78}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.375,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1790395200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPTX","date":"2026-10-08","current":-7.170111,"percent":0.990741,"low":-14.505892,"twenty":-12.644435,"median":-11.330579,"eighty":-9.343911,"high":-6.903604,"avg":-11.032351,"sd":1.844446,"marketCap":959802761},"quantilePoints":[{"date":"2026-05-08","current":-10.976498,"twenty":-12.440976,"median":-11.330579,"eighty":-11.259763,"marketCap":821931163},{"date":"2026-05-15","current":-11.99625,"twenty":-12.004748,"median":-11.348283,"eighty":-11.231436,"marketCap":898291219},{"date":"2026-05-22","current":-12.173291,"twenty":-12.004748,"median":-11.330579,"eighty":-11.135126,"marketCap":911548174},{"date":"2026-05-29","current":-13.31343,"twenty":-12.537286,"median":-11.684659,"eighty":-11.163453,"marketCap":996922959},{"date":"2026-06-05","current":-12.661922,"twenty":-12.698746,"median":-12.017495,"eighty":-11.247016,"marketCap":948137367},{"date":"2026-06-12","current":-12.548616,"twenty":-12.593938,"median":-12.03874,"eighty":-11.316416,"marketCap":939652917},{"date":"2026-06-18","current":-10.501726,"twenty":-12.6166,"median":-12.03874,"eighty":-11.222938,"marketCap":915372405},{"date":"2026-06-26","current":-11.889673,"twenty":-12.53162,"median":-11.895161,"eighty":-11.165224,"marketCap":1036351448},{"date":"2026-07-02","current":-13.173217,"twenty":-12.752567,"median":-12.017495,"eighty":-11.198861,"marketCap":1148230297},{"date":"2026-07-10","current":-12.595929,"twenty":-12.752567,"median":-12.03874,"eighty":-11.215593,"marketCap":1097911580},{"date":"2026-07-17","current":-11.987935,"twenty":-12.752567,"median":-12.12726,"eighty":-11.302253,"marketCap":1044916336},{"date":"2026-07-24","current":-13.474144,"twenty":-12.866109,"median":-12.187454,"eighty":-11.330579,"marketCap":1174460267},{"date":"2026-07-31","current":-12.479243,"twenty":-12.804736,"median":-12.201617,"eighty":-11.330579,"marketCap":1087740776},{"date":"2026-08-07","current":-14.1804,"twenty":-12.896856,"median":-12.347233,"eighty":-11.365987,"marketCap":1236020399},{"date":"2026-08-14","current":-9.423399,"twenty":-12.896856,"median":-12.221306,"eighty":-11.295171,"marketCap":1269209340},{"date":"2026-08-21","current":-9.552568,"twenty":-12.881452,"median":-12.180373,"eighty":-11.146457,"marketCap":1286606769},{"date":"2026-08-28","current":-10.432907,"twenty":-12.804736,"median":-12.123719,"eighty":-11.036024,"marketCap":1405176937},{"date":"2026-09-04","current":-9.653917,"twenty":-12.782309,"median":-12.017495,"eighty":-10.432907,"marketCap":1300257059},{"date":"2026-09-11","current":-9.252498,"twenty":-12.759648,"median":-11.944292,"eighty":-9.835946,"marketCap":1246191204},{"date":"2026-09-18","current":-8.67223,"twenty":-12.748317,"median":-11.889673,"eighty":-9.660275,"marketCap":1168036601},{"date":"2026-09-25","current":-8.394019,"twenty":-12.694907,"median":-11.667409,"eighty":-9.560914,"marketCap":1130565216},{"date":"2026-10-02","current":-7.531565,"twenty":-12.665919,"median":-11.472211,"eighty":-9.452015,"marketCap":1014403922},{"date":"2026-10-08","current":-7.126172,"twenty":-12.644435,"median":-11.330579,"eighty":-9.343911,"marketCap":959802761}],"updateTime":1791574468969},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPTX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674865001","title":"PureTech-Founded Seaport Therapeutics Unveils Strong Phase 1 Data for GlyphAgo","url":"https://stock-news.laohu8.com/highlight/detail?id=2674865001","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674865001?lang=en_us&edition=fundamental","pubTime":"2026-10-10 01:02","pubTimestamp":1791565369,"startTime":"0","endTime":"0","summary":"PureTech Health ( ($GB:PRTC) ) just unveiled an update. PureTech’s founded entity Seaport Therapeutics has presented detailed Phase 1 pharmacokinet...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/puretech-founded-seaport-therapeutics-unveils-strong-phase-1-data-for-glyphago?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/puretech-founded-seaport-therapeutics-unveils-strong-phase-1-data-for-glyphago?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674851885","title":"Seaport Therapeutics Says Drug Potentially Reduces Liver Impact of Depression Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2674851885","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674851885?lang=en_us&edition=fundamental","pubTime":"2026-10-09 20:01","pubTimestamp":1791547266,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics'  GlyphAgo showed a \"statistically significant\" 6.8-fold increase in bioavailability of the antidepressant agomelatine compared with unmodified agomelatine in a 174-patient phase 1 clinical trial, the company said Friday.GlyphAgo, designed to enhance lymphatic absorption of agomelatine, also achieved \"therapeutically relevant\" exposure of agomelatine at substantially lower doses meant to reduce liver damage, the company said.The drug also potentially reduces the risk of liver damage and the need for routine liver monitoring that has curtailed agomelatine's use to treat severe depression.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674784856","title":"Seaport Therapeutics presents additional PK data from Phase 1 GlyphAgo trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2674784856","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674784856?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:05","pubTimestamp":1791543929,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics (SPTX) announced the presentation of Phase 1 clinical data for GlyphAgo at the 39th European College of Neuropsychopharmacolog...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-presents-additional-pk-data-from-phase-1-glyphago-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-presents-additional-pk-data-from-phase-1-glyphago-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SPTX","EPV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674856867","title":"Seaport Therapeutics Presents Phase 1 GlyphAgo Data Showing 6.8-Fold Increase in Agomelatine Bioavailability","url":"https://stock-news.laohu8.com/highlight/detail?id=2674856867","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674856867?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:00","pubTimestamp":1791543643,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics presents Phase 1 GlyphAgo data showing 6.8-fold increase in agomelatine bioavailabilitySeaport Therapeutics disclosed additional Phase 1 pharmacokinetic data for GlyphAgo ahead of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nNDLc2RVJ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":19,"pageCount":1,"totalSize":73,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SPTX\",params:#limit:6,delay:false,,,undefined,":[]}}